{"ticker": {"uuid": "fc6edd35-9731-4914-91d6-4963d8d82068", "symbol": "NVON", "name": "Novo Nordisk A/S", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Novo Nordisk: 3 Key Reasons The 'Buy The Dip' Thesis Is Flawed (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPY1AtODM3Vm1wZElhSTc1dmdEaDlPZWVQUGJOcVhkLXdQcW9MMEZxNDJKNVdBdU1tZWJPa2VBMU5kNWkxYld4SFI2YlNlVmZKWlRkQkRLNUF5M2h0VDR4WENHMlZSQjYzMXZJMW53WjhLbTAxQnFsSW02dzB6a0laUEkyUFlQbW92R0xGeHRYcVY2eWFSTE5mSUdqa0llaGliVmc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: The Selloff Looks Like A Gift - And I'm Buying (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNT05zNWxfVEpyUlF5cVowY2NUNERlbDB3djdzSVNWblJ2R09fTnFqMDlfQzJKUnJkdEJldXM3Si1kNHVsLUtMUXl4STRIOTBlUk9IS0V1ZXFrNVo5cHFCUkU5Rm9CczY0N043RElGbDZXeDNwMUFtMHRaWFhPX0FXalF6aHEwbV9OT0VXRkFyQlVOWThmUXZGUmFwNHJyZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: A Fallen Leader Trading At Fair Value, Not A Bargain (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeGJOZDdTMGFXYUVxblRqZkF1VXRjcnFQSTVlRG5oX2NabHdBOUVoVm1fNnZsRjQwdFQyblpxcTdoYmFjaU9FdVBOMHdsRm9sUGhDdmFBWVhFelJnc0prQkpGaHZTY2tLQ21kT0lHaEMyTVpadHREbm5lN1ZKSi0yQ2VzRzdGajF3RmFEWDVyMzZnYXVBS1JQbF8tTjNYUUlFNnRVaHZ1MFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Why The Wegovy Pill Doesn't Change My Thesis", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPQ2dlbXNuYUpUZnZQSVIyeXVzTm04OC16VGI4aE1JRzhINXRBaVFiMVFJczI4UzBCaVpiNWw1Q0QtZ1pjcUZURkg3M3g3QldzN2gwU2l5dXRTQkRpel9paENxR2c5Y29CQlVBOXZlYjFWalhKSzdiMXJCY2pMbTVqbEF4SXdubTFIdGgzTUtieXJWc2VJS3BYeml6U2RtUQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Wegovy Pill Is Encouraging But Still Not Enough To Make Me Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQNWdCRklQUzlpenVmOEhRUm5rVmM4MlVWS3hFT1JOdGZzeS1DWEdoMmo4dTlOUGNNSGVnZjFlU19lT0VqYnRMYkNuTV9tTGhjUDNpN09QdVdfSVNVUXlIVHRIbmtaXzVRa1E5V2daOUtZTVZFblQ1NFR2SUVlbF91Q3FwTG1xQTVLT2dGX2dxV05HNWxDWTBXY0Q4cHpld29YeHJROGRRelF3WS13YXlPYXpjbkV4TUE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: The Biggest Healthcare Bargain (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNMHRxOUlmYjZMRkQ3dDlhR24wY1d3NGRWbnpnYWt4UmZQNkpwUFozTkdjQzNKeTVidGt3aEV1ak4xdUhsLU85aGIzLVBlY2wwMmM5MG83RmpNOHFPLTA2MWlTUURzc2tJc1BPTXpDVVdYaHZoSXBXZTVOdi1OeG81WnlpWnFLUTZFVi1wNg?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock (DK0062498333): Wegovy growth and U.S. demand stay in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQUEU4WEdoblQ0NFZmLUNuM2sxOWx1ZWZxN0t0SHVpVzRYVjYydF9pTzRBaW9fTWF5T2tGbGsyNmVoeDZSZFFNQ2NlclpqdEpJWWNueDVCY2N1UWV6N0p5ZW9Wb2dqMmtkUnFQeDVQMU16TElRTVQ4VkF6ejBJN0tzQlZ2dVVCV0VwR0ZRUDhFSXNsSmQ2d2ljc0g1S1pGVXJLS1B2c3hVR3RZWmdtdjdqaGxybDY0UkpxWF9pbEtXOHFJa0QyRnc?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk lifts 2026 outlook as Wegovy drives growth; shares jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOUHFDeGlNX05nd2l6OE5qYnEwRDhLdkl4bWlnanBvaXQwQUEtLW13bTNURVdBOXlSenJoU1R5YXp4MFBIVkktR0JaWWR3UUlhSFV1TUJCLUN4QnM5OFo4XzNwdHZiMm9CRzlsZDZ3ZU9TNzF5emZRSGhtVGhDMElyZHBTb2hxZGNSRWZfMThSUnpvcFdBdndUQmhLbnZjNDVWM2E2SGJB?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Misread Q1 Earnings, Mispriced Stock (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNMUdqc0pkZGU1cnlRTzctem9UZmtwQmFRWjNZUV9xV2tQX3dUdTJYVXRpbUpuc1BndF9Hb2hVNFJXenpPbEdUa3FqOTNQMTBSNnRXSHdtOHdIRm9OMzJ5UGZZbUQ2c1ZpUUkyXzRXZExQT2lPOVlNSG5kOXJvanM5VFp3ZUNGUVB0b0tDV0JQMm1iYkk?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Mixed Q1 Does Not Break The Thesis, But Also Does Not Strengthen It (NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNVXhIMVNOcmlmb0l6UmNDMmhSQjByVkNHOGRXRXBOdjloWkJoTVRPTjJ4Q3o0WWFTTFpFUWV1T2F0aTJHX2E4NDJMOFpnMjBvSFhuMmE3WEVNLXhrMjNVTERpcjhwSkZzT21ySUVOckdnQmJCdzdNTXFZZl9HYjVsWENTWE1ueTZfazZORm9MVGRFMDVYRkpscUtiQktmSV9LU01CQzlIUFZmR0hRRURlR0tpMDlrS1BkbEVTNQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: My Q1 Preview And Why I'm Doubling Down (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPRFpia2VESHdwR0RHeEpyN01TaG5DRkUyMWpSQVlGZnF4Q0M2dDZBdjhMenBEZml6Y1c4cW9LR2lNYkVaSkdwUHBidVZyRVJ3R3djUnRVN1h6S0MzMkdlLTItZXJZQmpjQ0hIWmFJR3JmVlczY21LalgzUHptWlVibS1Bc2VTNUxXVXIxS2NFU0pRbXo5dFF3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: A Generational Buying Opportunity Ahead Of Q1 Earnings (Preview) (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNMzNaQ0RvZ29KeW5xbE9rME9HdldtVEpyVkpYNEpXcExweG9OS3ZiZkxybHg3TVZGeEl1RVhJSnVQeVRSQWxlLXZTYkJWTXpnaGJlQ0gxUEFQZlU5TzBrR3FSN3dlNkgzT2ZiRlgxcUhzUWxSb3NueXV5Sm1DVmt5NzNmMGRJSkhVektuRGViMUJobk9qV3ZFcXNObXFIMC1fcFhPeHlvXzkzc1RIT1RJZjZ3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Is The GLP\u20111 Golden Age Already Behind It? (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNeUpzWUk3Vi1xS005WFJmaXRzODd3VGIxZ09LVEJBTl80QXZrNGtOUUxhRTI5Z0wxVlBPT21Qa1lkVENYWkdOaENKTE8zMXFxNFViUDhrcGhDOGs3cnM1dW13VUNIandIXzBqeGc2TTdWVnFUMW15SE1wRms4X1JvT1YyUEVHSkloWlNxa2lFYkJ6UG90VUNvLWV3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's Weight Loss Doesn't Mean To Load Up (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQS1MWUpaY19uYWFNZGhHdlZ0VzU1WFowb1BJYXp0VWt3Z19kUzlmQ1k5cnJYTVVYX3otczFHdzdBMWd1NXl4S21YSTJIR1JLcGQ2RWh0V00tOVA2WW5zV2Eza1BQb3NQRnJEMXJOa3g3V0c1Sm10VFhSNEMxVXlkQ3lkczcwNVVtUnZfWE80X2owZmc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Don't Stop Purchasing The Dip (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQM2czZDc3aDRRYXBzaWNsbHNZUnlmaG92UGNoVTVhV29vdEQtdjI2MXE3SnhsaFVGWXhxVzVXVkQwbE1aZ2IwTzRzVlJwQ3JCZnVYdWFjUExlbDI3aGltZHVaWGdMR3h1N2xrTTZnRWdKMG1Sb00xcW5UU0k2djNlZGtZOXJCNVBmX3c?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeUFjeXNmZHFzWlZ0dC1jdVlpaDZYYVBVT1YxdGlTMXBibUVGbm9iejdDYW5ZSktsM3ZzREw3YXJLSVlscGNBZFJobnFSem5JaHNDQkZGZTMtTGtta2lfMG1GR3U0eWpMYzNSQmFIa1JwV0pkS3VzemJ0ZlJrLWdaTFRadHNmSUtSQ0dZcWhoMEJwSTlYV09ZcUYzS1lUYWNEWEZyTFBfMDN0aXRiLVNJVWpzYjNzT3l3ZDJfU3Y3eFE?oc=5", "source_name": "Barchart.com", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Why I Still Find It An Interesting Opportunity (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPZWx4d2dxdVJNNVdnZEJQSEFhcV9UTGFJbWJMQllUbTNsOWNwRVdJald0WXZZeEh1cC1VTy1mQlZQbjJwaWhSTC1HWjJSZFQwUDlUUzgyYXhtREVENmVCTFp5N2pObjJrNzZGTFZUNFgxdWlyU193Rlc3MmhJUnlZVVp5aVdsS01zVWFFeWNCY0FHTkdOcjg2MUhzSE5JV2tscEE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Buying The Dip Before Volume Dominance (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNdTUzcFcwcVlXazYzdnlGQVhkSGxYMS1GRThOaHNPMEpKdDhQcWpZVE1od3czVjF3VGhkUHdBdlpvV3Uzd0tGV2R2WEljMXBBNVN5dUZnNXZlZHpCcEoxRjJqdWs1Y2NTbFJCaHB5a0NOVzNzekNLdHdxcmRJN2doQkVHTU13MVZDUHZqcVJXM1Y0VGNLejBz?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why I'm Still Bullish On Novo Nordisk Despite Recent Setbacks (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQSkZiMnNjUnJINmRld0ZFbjl6aUp5TUFKTXVUWnotZEJlMlNjaFh0Y1JibUNqSVFwTlFKMFBILVNEajNnS3l2TnpGRmVHOUN2dnBSWWRNT1VRd3hRalliX21WanBRb0xoY0E5Q1pCdHpzZWZ0cFpURFpYekR2LWg4Z0ZIOGlCQl9ncjE5T1R2LVBLUWhFQnhJTg?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Why Wegovy Growth Beats Wall Street Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNY0pQcXd6N1VZdjdFMDRTR0lOejd0YWtSTlFwa2tKdTJRbUZQMlBsMHlBQ2hidklGSmZLNHExSjhuZXhuSUc2N2lBTHcwd2hsNmhGVW1SQlBwOFI4TEt3UkprUG5ITW9CZjJxaS1GY0w3TXlGemE3MHFRVDZMWDM2TnZzRjEtOHR2TVNIUC1QNnEzUEtSQy1jTjJGNTZWekZOdG9Gdw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Ugly Guidance, But Stock Refuses To Break Down Further (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPeHBtTVdTdG5CcjRydk5NVUhLSDQ5QVRwQWZnODcwNTNrOVQ4elRZVG9fM3E4OVVMMDB1cnRTcU5nNGhUOWt2YkhfUk9yeHpLTVk3elFxaUl1TTFULVJBXzhoVTZmbTFNSWZ0TkxVM0FWb0ZjczczclBvZlh5UWxCeWp0NmZrNnhJSFVjbnUtSXh4cl9vNFpIMVNSWFJHYVZfQjBPUmR0cHJEWkk?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Files Patent Lawsuit Against Hims & Hers Over Compounded Semaglutide Products", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOcUtRUG1LbTVybjF5NTliRXRIeGV3TWVGTGxxT1psSWU5VXQzb0RPQ0RSQWJWWVVQRHVQY0VfOXRJTTdubnVvQWpzWHh4XzRScGFCbEhDODFndUZuVlJ6c25nSnk0VHhkdk1Xd3g5UDdLWmhVb2JLWER4M1l3bjBLUW5NV1hFZFktbWNCTGpzQnU1SUFXV0oyY1dzaVpzdm9jSzc2NnhRbDRrU1ZQRnlqclpLRlUzOTB4b2ZUWVdHOHhJTk9KSVE?oc=5", "source_name": "Law Commentary", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: How Low Is Too Low? (Downgrade, Technical Analysis) (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNeEo4aEdwVy1UdURKazJySlh3RnZfcEg0eHNKVTRSVDNXaGtIcmhCNk92QXE2Umx1Y2lScTlkWW9Fb040OWFXLVlfU1BQLTNHbXczODd2SURGeUlrbElUSndoVGNUR1FtUk1YMmdFYUpYb0ctc19Qc0FTUTdzZEYwNWp5Vms5Q2pNalhhOERyaW9pdV9tZW9fci11OFJNdXRxY0lV?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: A Game Of Price Vs. Volume (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPdzZWNzZKOWZpN1N3dmY1VVFhZkRZYjRRLVVQeW1BbF9DOVNQMmZNSmRFMG5xN3pRMDFXaUwxR1ZsWnRSSWtvSXk1Q1BqRklKbmphVEN6VDJHSVVva0Zma2VicXRsZGttQUhGU0stQ3FMRnUxbXFhdDYycDBwbnY3a1BsNzN2QQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Q4: Slumping Due To Weak Guidance (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQdDZjdEd1a04xRGpDbmJ0V0M2WTlubVczVk5ZZXhGbnRqSEZVTHhydF9OdWdERC01d2tYVTVESDRIQUJHbjJBekhZOTJJYkFRYmF2bU9SZlZDQVhLeVFBeE5JN3FtSFpWSFc0OG1rbmZXOU1uVlA1SUR1N0pnY1lkcDRhdEVuSHpHWW45NVBGWQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares fall 18% amid lower 2026 sales outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOQTNhNGZrQ0VEYUxXdllVYzFTRFJRd0VNVlBmS190dE9aRnoyaEtTbnFQTFcyQkVBN1YxYi1sZ0xrZVVWWmg1WW9wTTQzNzdxMFQyVkt4MFZPeEwwbFdnUmF1eGZsZFBleGVtVnVveGZhOFlqUHlOVlZqc0xFQWdBYUVMMS1tNGlPYmRjbU9Iak5KQVh2dW95M0pxM3lQRzFPVWJnRHpzUE9wVUVNNl82eWVPZw?oc=5", "source_name": "Investing.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 6, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQNEZ6MWVaRXMwM2ZLSkVzcFRUVGtUajRubm5wVGxrdF9qTkNpNC10ZDJDb18wb1dEb1lncXhGYmpHNHFpNmV3N2s0OWxsdkVCRVltLTNBTm1YWFJGM2hJOW5qSzRiS3ZrVlJQZHRxZWY0OUZHSXVxb3N1S0JmRnVHa2VRODVxTnZoVEVtOUIxWElZdTN3Q3hMbzJTalIxWFR2UnJYU0hCcw?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock soars after FDA approves first oral GLP-1 for weight loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQbkVMUHNPalZHMWRMdUhhT0RSTTBhcDhiel9IcnBmcWNJaWdpclpPMGJjS09yN1VCR1UwVU1IVTlHaEsyQUtxVGFDMXA1ODdUVTFDTmlPWDNjWnQybFB2LU44VXN5aXlpSUxiNGxkNG1IeUE4cVZUOGJMcTRrcTAtcTNXLTJQWWhXaXA5OVUwdlB4RVJwTnk4RG5mN0RINFlSVjVoNXlEdXNlWDZsZkVLVC1nTGVsclJKVEF1MmtMaTZSX0NKNmNtcDJlRFA?oc=5", "source_name": "Investing.com", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Is Trading as If Obesity Drug Craze Never Happened", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPQzJ6NnRnQk1pTnF6Q0RsM3VUeUNJMmtxYkFiNnJ1VmZ3ald2Q0x5Tk9NVkJEOWNvb01Bb0lGWk9Va1QxWGZ6a2V3ODJOVjJXZXdXYnppVXVQY3NfVDZab3k1RHpHWGxUYS1NVVNPTldqY0ZkU0VtQ0xxdDM1Tzh4d00yWFBETkNzRVJpZnNLVVRJRk1XSjVDcXpfcUh1Q3Vrd0pyX001c0dqSTliRnNxVElHSnE?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-12-10T08:00:00+00:00", "published_display": "10 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPRUwxUEJDOWFiRUpWQTlOell4VDlsR0hlbDdZR2dfN2FMMVZLRkctNmhORjU4UnVxOUZ1NTU0RXpPTmxwR1lxd0JCcjd3VS1zbHd2RUFBYXh1Z0t5SGs1QnRIM3RNXy1KUDRQWHRCNDI4bk9pb0ZoYml6ZTNndDI4b0NBVzVtX1M0T01rd0xER0lSaHNlQkdKT0MyODZ6WWJBQUh5MUN2dTZXMGJnZXgyMzRSMV92VERiRkZyYWYyMUpNeGI1bEwtUU93R0F2TVZRRVdlak9RVEVGdnlKYUE?oc=5", "source_name": "Reuters", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares fall as obesity pipeline faces investor scrutiny", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPRURhLU1RbmZtejlyY2lXU2pxeGlXQjlCcHpsOW9uWXNGUTVqMEtCb2VtNDY5cU1yNFliblFXQkZiLWdVbTYxOVVEZkROMGk1UkpTOUJ5Q1pURjRza0t2QjJmcHIwY2Vuc2hIdko1YlB5VjYyTU56d055SFhxdWtLbkFydU9JUFVlTFdzU0g0bEUtRU9hZ1ZZcm9SWC12cU85bFA2LWFndk5WLXVKeU5EclJTSXdTMEM5d19xVkxLRVVERUJSN0hMTnZxV2Rqc2VVcXNz?oc=5", "source_name": "Reuters", "published_at": "2025-06-23T07:00:00+00:00", "published_display": "23 Jun 2025 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Novo Nordisk: 3 Key Reasons The 'Buy The Dip' Thesis Is Flawed (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPY1AtODM3Vm1wZElhSTc1dmdEaDlPZWVQUGJOcVhkLXdQcW9MMEZxNDJKNVdBdU1tZWJPa2VBMU5kNWkxYld4SFI2YlNlVmZKWlRkQkRLNUF5M2h0VDR4WENHMlZSQjYzMXZJMW53WjhLbTAxQnFsSW02dzB6a0laUEkyUFlQbW92R0xGeHRYcVY2eWFSTE5mSUdqa0llaGliVmc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: The Selloff Looks Like A Gift - And I'm Buying (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNT05zNWxfVEpyUlF5cVowY2NUNERlbDB3djdzSVNWblJ2R09fTnFqMDlfQzJKUnJkdEJldXM3Si1kNHVsLUtMUXl4STRIOTBlUk9IS0V1ZXFrNVo5cHFCUkU5Rm9CczY0N043RElGbDZXeDNwMUFtMHRaWFhPX0FXalF6aHEwbV9OT0VXRkFyQlVOWThmUXZGUmFwNHJyZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: A Fallen Leader Trading At Fair Value, Not A Bargain (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeGJOZDdTMGFXYUVxblRqZkF1VXRjcnFQSTVlRG5oX2NabHdBOUVoVm1fNnZsRjQwdFQyblpxcTdoYmFjaU9FdVBOMHdsRm9sUGhDdmFBWVhFelJnc0prQkpGaHZTY2tLQ21kT0lHaEMyTVpadHREbm5lN1ZKSi0yQ2VzRzdGajF3RmFEWDVyMzZnYXVBS1JQbF8tTjNYUUlFNnRVaHZ1MFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Why The Wegovy Pill Doesn't Change My Thesis", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPQ2dlbXNuYUpUZnZQSVIyeXVzTm04OC16VGI4aE1JRzhINXRBaVFiMVFJczI4UzBCaVpiNWw1Q0QtZ1pjcUZURkg3M3g3QldzN2gwU2l5dXRTQkRpel9paENxR2c5Y29CQlVBOXZlYjFWalhKSzdiMXJCY2pMbTVqbEF4SXdubTFIdGgzTUtieXJWc2VJS3BYeml6U2RtUQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Wegovy Pill Is Encouraging But Still Not Enough To Make Me Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQNWdCRklQUzlpenVmOEhRUm5rVmM4MlVWS3hFT1JOdGZzeS1DWEdoMmo4dTlOUGNNSGVnZjFlU19lT0VqYnRMYkNuTV9tTGhjUDNpN09QdVdfSVNVUXlIVHRIbmtaXzVRa1E5V2daOUtZTVZFblQ1NFR2SUVlbF91Q3FwTG1xQTVLT2dGX2dxV05HNWxDWTBXY0Q4cHpld29YeHJROGRRelF3WS13YXlPYXpjbkV4TUE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: The Biggest Healthcare Bargain (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNMHRxOUlmYjZMRkQ3dDlhR24wY1d3NGRWbnpnYWt4UmZQNkpwUFozTkdjQzNKeTVidGt3aEV1ak4xdUhsLU85aGIzLVBlY2wwMmM5MG83RmpNOHFPLTA2MWlTUURzc2tJc1BPTXpDVVdYaHZoSXBXZTVOdi1OeG81WnlpWnFLUTZFVi1wNg?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock (DK0062498333): Wegovy growth and U.S. demand stay in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQUEU4WEdoblQ0NFZmLUNuM2sxOWx1ZWZxN0t0SHVpVzRYVjYydF9pTzRBaW9fTWF5T2tGbGsyNmVoeDZSZFFNQ2NlclpqdEpJWWNueDVCY2N1UWV6N0p5ZW9Wb2dqMmtkUnFQeDVQMU16TElRTVQ4VkF6ejBJN0tzQlZ2dVVCV0VwR0ZRUDhFSXNsSmQ2d2ljc0g1S1pGVXJLS1B2c3hVR3RZWmdtdjdqaGxybDY0UkpxWF9pbEtXOHFJa0QyRnc?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk lifts 2026 outlook as Wegovy drives growth; shares jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOUHFDeGlNX05nd2l6OE5qYnEwRDhLdkl4bWlnanBvaXQwQUEtLW13bTNURVdBOXlSenJoU1R5YXp4MFBIVkktR0JaWWR3UUlhSFV1TUJCLUN4QnM5OFo4XzNwdHZiMm9CRzlsZDZ3ZU9TNzF5emZRSGhtVGhDMElyZHBTb2hxZGNSRWZfMThSUnpvcFdBdndUQmhLbnZjNDVWM2E2SGJB?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Misread Q1 Earnings, Mispriced Stock (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNMUdqc0pkZGU1cnlRTzctem9UZmtwQmFRWjNZUV9xV2tQX3dUdTJYVXRpbUpuc1BndF9Hb2hVNFJXenpPbEdUa3FqOTNQMTBSNnRXSHdtOHdIRm9OMzJ5UGZZbUQ2c1ZpUUkyXzRXZExQT2lPOVlNSG5kOXJvanM5VFp3ZUNGUVB0b0tDV0JQMm1iYkk?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Mixed Q1 Does Not Break The Thesis, But Also Does Not Strengthen It (NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNVXhIMVNOcmlmb0l6UmNDMmhSQjByVkNHOGRXRXBOdjloWkJoTVRPTjJ4Q3o0WWFTTFpFUWV1T2F0aTJHX2E4NDJMOFpnMjBvSFhuMmE3WEVNLXhrMjNVTERpcjhwSkZzT21ySUVOckdnQmJCdzdNTXFZZl9HYjVsWENTWE1ueTZfazZORm9MVGRFMDVYRkpscUtiQktmSV9LU01CQzlIUFZmR0hRRURlR0tpMDlrS1BkbEVTNQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: My Q1 Preview And Why I'm Doubling Down (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPRFpia2VESHdwR0RHeEpyN01TaG5DRkUyMWpSQVlGZnF4Q0M2dDZBdjhMenBEZml6Y1c4cW9LR2lNYkVaSkdwUHBidVZyRVJ3R3djUnRVN1h6S0MzMkdlLTItZXJZQmpjQ0hIWmFJR3JmVlczY21LalgzUHptWlVibS1Bc2VTNUxXVXIxS2NFU0pRbXo5dFF3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: A Generational Buying Opportunity Ahead Of Q1 Earnings (Preview) (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNMzNaQ0RvZ29KeW5xbE9rME9HdldtVEpyVkpYNEpXcExweG9OS3ZiZkxybHg3TVZGeEl1RVhJSnVQeVRSQWxlLXZTYkJWTXpnaGJlQ0gxUEFQZlU5TzBrR3FSN3dlNkgzT2ZiRlgxcUhzUWxSb3NueXV5Sm1DVmt5NzNmMGRJSkhVektuRGViMUJobk9qV3ZFcXNObXFIMC1fcFhPeHlvXzkzc1RIT1RJZjZ3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Is The GLP\u20111 Golden Age Already Behind It? (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNeUpzWUk3Vi1xS005WFJmaXRzODd3VGIxZ09LVEJBTl80QXZrNGtOUUxhRTI5Z0wxVlBPT21Qa1lkVENYWkdOaENKTE8zMXFxNFViUDhrcGhDOGs3cnM1dW13VUNIandIXzBqeGc2TTdWVnFUMW15SE1wRms4X1JvT1YyUEVHSkloWlNxa2lFYkJ6UG90VUNvLWV3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's Weight Loss Doesn't Mean To Load Up (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQS1MWUpaY19uYWFNZGhHdlZ0VzU1WFowb1BJYXp0VWt3Z19kUzlmQ1k5cnJYTVVYX3otczFHdzdBMWd1NXl4S21YSTJIR1JLcGQ2RWh0V00tOVA2WW5zV2Eza1BQb3NQRnJEMXJOa3g3V0c1Sm10VFhSNEMxVXlkQ3lkczcwNVVtUnZfWE80X2owZmc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Don't Stop Purchasing The Dip (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQM2czZDc3aDRRYXBzaWNsbHNZUnlmaG92UGNoVTVhV29vdEQtdjI2MXE3SnhsaFVGWXhxVzVXVkQwbE1aZ2IwTzRzVlJwQ3JCZnVYdWFjUExlbDI3aGltZHVaWGdMR3h1N2xrTTZnRWdKMG1Sb00xcW5UU0k2djNlZGtZOXJCNVBmX3c?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeUFjeXNmZHFzWlZ0dC1jdVlpaDZYYVBVT1YxdGlTMXBibUVGbm9iejdDYW5ZSktsM3ZzREw3YXJLSVlscGNBZFJobnFSem5JaHNDQkZGZTMtTGtta2lfMG1GR3U0eWpMYzNSQmFIa1JwV0pkS3VzemJ0ZlJrLWdaTFRadHNmSUtSQ0dZcWhoMEJwSTlYV09ZcUYzS1lUYWNEWEZyTFBfMDN0aXRiLVNJVWpzYjNzT3l3ZDJfU3Y3eFE?oc=5", "source_name": "Barchart.com", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Why I Still Find It An Interesting Opportunity (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPZWx4d2dxdVJNNVdnZEJQSEFhcV9UTGFJbWJMQllUbTNsOWNwRVdJald0WXZZeEh1cC1VTy1mQlZQbjJwaWhSTC1HWjJSZFQwUDlUUzgyYXhtREVENmVCTFp5N2pObjJrNzZGTFZUNFgxdWlyU193Rlc3MmhJUnlZVVp5aVdsS01zVWFFeWNCY0FHTkdOcjg2MUhzSE5JV2tscEE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Buying The Dip Before Volume Dominance (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNdTUzcFcwcVlXazYzdnlGQVhkSGxYMS1GRThOaHNPMEpKdDhQcWpZVE1od3czVjF3VGhkUHdBdlpvV3Uzd0tGV2R2WEljMXBBNVN5dUZnNXZlZHpCcEoxRjJqdWs1Y2NTbFJCaHB5a0NOVzNzekNLdHdxcmRJN2doQkVHTU13MVZDUHZqcVJXM1Y0VGNLejBz?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why I'm Still Bullish On Novo Nordisk Despite Recent Setbacks (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQSkZiMnNjUnJINmRld0ZFbjl6aUp5TUFKTXVUWnotZEJlMlNjaFh0Y1JibUNqSVFwTlFKMFBILVNEajNnS3l2TnpGRmVHOUN2dnBSWWRNT1VRd3hRalliX21WanBRb0xoY0E5Q1pCdHpzZWZ0cFpURFpYekR2LWg4Z0ZIOGlCQl9ncjE5T1R2LVBLUWhFQnhJTg?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Why Wegovy Growth Beats Wall Street Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNY0pQcXd6N1VZdjdFMDRTR0lOejd0YWtSTlFwa2tKdTJRbUZQMlBsMHlBQ2hidklGSmZLNHExSjhuZXhuSUc2N2lBTHcwd2hsNmhGVW1SQlBwOFI4TEt3UkprUG5ITW9CZjJxaS1GY0w3TXlGemE3MHFRVDZMWDM2TnZzRjEtOHR2TVNIUC1QNnEzUEtSQy1jTjJGNTZWekZOdG9Gdw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: Ugly Guidance, But Stock Refuses To Break Down Further (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPeHBtTVdTdG5CcjRydk5NVUhLSDQ5QVRwQWZnODcwNTNrOVQ4elRZVG9fM3E4OVVMMDB1cnRTcU5nNGhUOWt2YkhfUk9yeHpLTVk3elFxaUl1TTFULVJBXzhoVTZmbTFNSWZ0TkxVM0FWb0ZjczczclBvZlh5UWxCeWp0NmZrNnhJSFVjbnUtSXh4cl9vNFpIMVNSWFJHYVZfQjBPUmR0cHJEWkk?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Files Patent Lawsuit Against Hims & Hers Over Compounded Semaglutide Products", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOcUtRUG1LbTVybjF5NTliRXRIeGV3TWVGTGxxT1psSWU5VXQzb0RPQ0RSQWJWWVVQRHVQY0VfOXRJTTdubnVvQWpzWHh4XzRScGFCbEhDODFndUZuVlJ6c25nSnk0VHhkdk1Xd3g5UDdLWmhVb2JLWER4M1l3bjBLUW5NV1hFZFktbWNCTGpzQnU1SUFXV0oyY1dzaVpzdm9jSzc2NnhRbDRrU1ZQRnlqclpLRlUzOTB4b2ZUWVdHOHhJTk9KSVE?oc=5", "source_name": "Law Commentary", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: How Low Is Too Low? (Downgrade, Technical Analysis) (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNeEo4aEdwVy1UdURKazJySlh3RnZfcEg0eHNKVTRSVDNXaGtIcmhCNk92QXE2Umx1Y2lScTlkWW9Fb040OWFXLVlfU1BQLTNHbXczODd2SURGeUlrbElUSndoVGNUR1FtUk1YMmdFYUpYb0ctc19Qc0FTUTdzZEYwNWp5Vms5Q2pNalhhOERyaW9pdV9tZW9fci11OFJNdXRxY0lV?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk: A Game Of Price Vs. Volume (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPdzZWNzZKOWZpN1N3dmY1VVFhZkRZYjRRLVVQeW1BbF9DOVNQMmZNSmRFMG5xN3pRMDFXaUwxR1ZsWnRSSWtvSXk1Q1BqRklKbmphVEN6VDJHSVVva0Zma2VicXRsZGttQUhGU0stQ3FMRnUxbXFhdDYycDBwbnY3a1BsNzN2QQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Q4: Slumping Due To Weak Guidance (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQdDZjdEd1a04xRGpDbmJ0V0M2WTlubVczVk5ZZXhGbnRqSEZVTHhydF9OdWdERC01d2tYVTVESDRIQUJHbjJBekhZOTJJYkFRYmF2bU9SZlZDQVhLeVFBeE5JN3FtSFpWSFc0OG1rbmZXOU1uVlA1SUR1N0pnY1lkcDRhdEVuSHpHWW45NVBGWQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares fall 18% amid lower 2026 sales outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOQTNhNGZrQ0VEYUxXdllVYzFTRFJRd0VNVlBmS190dE9aRnoyaEtTbnFQTFcyQkVBN1YxYi1sZ0xrZVVWWmg1WW9wTTQzNzdxMFQyVkt4MFZPeEwwbFdnUmF1eGZsZFBleGVtVnVveGZhOFlqUHlOVlZqc0xFQWdBYUVMMS1tNGlPYmRjbU9Iak5KQVh2dW95M0pxM3lQRzFPVWJnRHpzUE9wVUVNNl82eWVPZw?oc=5", "source_name": "Investing.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 6, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQNEZ6MWVaRXMwM2ZLSkVzcFRUVGtUajRubm5wVGxrdF9qTkNpNC10ZDJDb18wb1dEb1lncXhGYmpHNHFpNmV3N2s0OWxsdkVCRVltLTNBTm1YWFJGM2hJOW5qSzRiS3ZrVlJQZHRxZWY0OUZHSXVxb3N1S0JmRnVHa2VRODVxTnZoVEVtOUIxWElZdTN3Q3hMbzJTalIxWFR2UnJYU0hCcw?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock soars after FDA approves first oral GLP-1 for weight loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQbkVMUHNPalZHMWRMdUhhT0RSTTBhcDhiel9IcnBmcWNJaWdpclpPMGJjS09yN1VCR1UwVU1IVTlHaEsyQUtxVGFDMXA1ODdUVTFDTmlPWDNjWnQybFB2LU44VXN5aXlpSUxiNGxkNG1IeUE4cVZUOGJMcTRrcTAtcTNXLTJQWWhXaXA5OVUwdlB4RVJwTnk4RG5mN0RINFlSVjVoNXlEdXNlWDZsZkVLVC1nTGVsclJKVEF1MmtMaTZSX0NKNmNtcDJlRFA?oc=5", "source_name": "Investing.com", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Is Trading as If Obesity Drug Craze Never Happened", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPQzJ6NnRnQk1pTnF6Q0RsM3VUeUNJMmtxYkFiNnJ1VmZ3ald2Q0x5Tk9NVkJEOWNvb01Bb0lGWk9Va1QxWGZ6a2V3ODJOVjJXZXdXYnppVXVQY3NfVDZab3k1RHpHWGxUYS1NVVNPTldqY0ZkU0VtQ0xxdDM1Tzh4d00yWFBETkNzRVJpZnNLVVRJRk1XSjVDcXpfcUh1Q3Vrd0pyX001c0dqSTliRnNxVElHSnE?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-12-10T08:00:00+00:00", "published_display": "10 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPRUwxUEJDOWFiRUpWQTlOell4VDlsR0hlbDdZR2dfN2FMMVZLRkctNmhORjU4UnVxOUZ1NTU0RXpPTmxwR1lxd0JCcjd3VS1zbHd2RUFBYXh1Z0t5SGs1QnRIM3RNXy1KUDRQWHRCNDI4bk9pb0ZoYml6ZTNndDI4b0NBVzVtX1M0T01rd0xER0lSaHNlQkdKT0MyODZ6WWJBQUh5MUN2dTZXMGJnZXgyMzRSMV92VERiRkZyYWYyMUpNeGI1bEwtUU93R0F2TVZRRVdlak9RVEVGdnlKYUE?oc=5", "source_name": "Reuters", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares fall as obesity pipeline faces investor scrutiny", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPRURhLU1RbmZtejlyY2lXU2pxeGlXQjlCcHpsOW9uWXNGUTVqMEtCb2VtNDY5cU1yNFliblFXQkZiLWdVbTYxOVVEZkROMGk1UkpTOUJ5Q1pURjRza0t2QjJmcHIwY2Vuc2hIdko1YlB5VjYyTU56d055SFhxdWtLbkFydU9JUFVlTFdzU0g0bEUtRU9hZ1ZZcm9SWC12cU85bFA2LWFndk5WLXVKeU5EclJTSXdTMEM5d19xVkxLRVVERUJSN0hMTnZxV2Rqc2VVcXNz?oc=5", "source_name": "Reuters", "published_at": "2025-06-23T07:00:00+00:00", "published_display": "23 Jun 2025 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 31, "sentiment_summary": {"positive": 7, "negative": 7, "neutral": 17, "score": 50, "total": 31, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 18.2, "count": 21}, {"event": "guidance", "label": "Guidance", "weight": 3.45, "count": 5}, {"event": "earnings", "label": "Earnings", "weight": 1.8, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.9, "count": 1}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 889.66, "latest_week": "2026-07-17", "one_week_move": 3.0, "four_week_move": 17.8, "twelve_week_move": 24.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.099107, "market_dynamics_buy_signal": false, "relative_strength": -2.599206, "fair_value_gap": -43.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 47.5888, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.0% over one week, +17.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Seeking Alpha", "count": 21}, {"label": "Investing.com", "count": 3}, {"label": "Reuters", "count": 2}, {"label": "Ad-hoc-news.de", "count": 1}, {"label": "Barchart.com", "count": 1}, {"label": "Law Commentary", "count": 1}, {"label": "24/7 Wall St.", "count": 1}, {"label": "Bloomberg.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 31}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 21}, {"label": "Guidance", "count": 5}, {"label": "Earnings", "count": 2}, {"label": "Macro sensitivity", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "31", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "24", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.0% over one week, +17.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Novo Nordisk: 3 Key Reasons The 'Buy The Dip' Thesis Is Flawed (NYSE:NVO)"}], "updated_at": "2026-07-21T17:46:45.461253+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}